Fraser Johnson

800 total citations
10 papers, 341 citations indexed

About

Fraser Johnson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fraser Johnson has authored 10 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Fraser Johnson's work include Ubiquitin and proteasome pathways (3 papers), Prostate Cancer Treatment and Research (3 papers) and Advanced Proteomics Techniques and Applications (2 papers). Fraser Johnson is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Prostate Cancer Treatment and Research (3 papers) and Advanced Proteomics Techniques and Applications (2 papers). Fraser Johnson collaborates with scholars based in Canada, United States and Austria. Fraser Johnson's co-authors include Amina Zoubeidi, Dong Lin, Ladan Fazli, Colin C. Collins, Randy Jama, Himisha Beltran, Daksh Thaper, Alexander W. Wyatt, Alastair Davies and Yuzhuo Wang and has published in prestigious journals such as PLoS ONE, Oncogene and Journal of Cell Science.

In The Last Decade

Fraser Johnson

10 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fraser Johnson Canada	6	246	212	91	90	35	10	341
Randy Jama Canada	2	213 0.9×	162 0.8×	69 0.8×	72 0.8×	35 1.0×	2	269
Louie Semaan United States	8	139 0.6×	169 0.8×	88 1.0×	106 1.2×	25 0.7×	10	347
Chuandong Geng United States	6	232 0.9×	309 1.5×	132 1.5×	136 1.5×	19 0.5×	7	485
Ninghui Mao United States	13	137 0.6×	262 1.2×	57 0.6×	71 0.8×	56 1.6×	19	406
John Shou United States	4	190 0.8×	229 1.1×	115 1.3×	52 0.6×	13 0.4×	8	348
Hetty A. van der Korput Netherlands	6	261 1.1×	288 1.4×	84 0.9×	66 0.7×	22 0.6×	6	430
Kati Kivinummi Finland	9	205 0.8×	241 1.1×	191 2.1×	61 0.7×	18 0.5×	12	383
Laia Perez‐Roca Spain	9	197 0.8×	212 1.0×	124 1.4×	137 1.5×	20 0.6×	11	393
Ehsan Irajizad United States	10	80 0.3×	193 0.9×	92 1.0×	77 0.9×	45 1.3×	31	318
Ahn R. Lee Canada	10	164 0.7×	220 1.0×	85 0.9×	54 0.6×	54 1.5×	13	323

Countries citing papers authored by Fraser Johnson

Since Specialization

Citations

This map shows the geographic impact of Fraser Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fraser Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fraser Johnson more than expected).

Fields of papers citing papers by Fraser Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fraser Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fraser Johnson. The network helps show where Fraser Johnson may publish in the future.

Co-authorship network of co-authors of Fraser Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Fraser Johnson. A scholar is included among the top collaborators of Fraser Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fraser Johnson. Fraser Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Johnson, Fraser, Sahil Kumar, Olena Sivak, et al.. (2024). Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308. Oncology Reports. 52(4). 1 indexed citations

Johnson, Fraser, Rocky Shi, Daniel Lu, et al.. (2024). Characterizing the secretome of EGFR mutant lung adenocarcinoma. Frontiers in Oncology. 13. 1286821–1286821. 1 indexed citations

Marshall, Erin A., Avery J. C. Noonan, Fernando Sergio Leitão Filho, et al.. (2023). Methionine-producing tumor micro(be) environment fuels growth of solid tumors. Cellular Oncology. 46(6). 1659–1673. 10 indexed citations

Johnson, Fraser, Christopher S. Hughes, Alvin Liu, William W. Lockwood, & Gregg B. Morin. (2023). Tandem mass tag-based thermal proteome profiling for the discovery of drug-protein interactions in cancer cells. STAR Protocols. 4(1). 102012–102012. 3 indexed citations

Chittaranjan, Suganthi, Steve E. Kalloger, Jennifer A. Chan, et al.. (2023). Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. Journal of Cell Science. 136(19). 3 indexed citations

Inoue, Yusuke, Fraser Johnson, Daniel Lu, et al.. (2022). MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression. npj Precision Oncology. 6(1). 88–88. 7 indexed citations

Inoue, Yusuke, Ana Nikolić, Rocky Shi, et al.. (2021). Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer. eLife. 10. 20 indexed citations

Zhang, Fan, Amal M. El-Naggar, Gian Luca Negri, et al.. (2021). HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner. Oncogene. 40(11). 1988–2001. 6 indexed citations

Bishop, Jennifer L., Daksh Thaper, Sepideh Vahid, et al.. (2016). The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer. Cancer Discovery. 7(1). 54–71. 263 indexed citations

10.

Toren, Paul, Soojin Kim, Fraser Johnson, & Amina Zoubeidi. (2016). Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer. PLoS ONE. 11(4). e0152861–e0152861. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact